RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 56-66
  • Health care non-profits invited to bid for bucks

     
    Does your health care non-profit have an impact on the community? GlaxoSmithKline wants to know. The pharmaceutical company is holding its 16th annual IMPACT awards to recognize community-based nonprofits that provide access to healthcare for the...
  • Men taking erectile dysfunction drugs risk STDs

    Men taking erectile dysfunction drugs risk STDs
    Men who took erectile dysfunction drugs such as Viagra were more likely to become infected with sexually transmitted diseases, including AIDS, U.S. researchers have reported. This infection rate was higher even in the year before the men got their...
  • Consumer Confidential: Chevron profits, Wells penalty fee, nurdle rights

     
    Here's your frosted-flakes Friday roundup of consumer news from around the Web: -- Well, all I can say is, "Thank goodness!" Our friends at Chevron are pleased to report that their quarterly profit more than tripled to $5.4 billion from......
  • Lupus education event in Orlando

     
    Lupus is a challenging disease that often leaves patients feeling alone and misunderstood. While many patients might not “look” sick, they may be silently managing the debilitating pain, fatigue and other symptoms associated with lupus. This...
  • Malaria vaccine: The fiction and the reality

     
    Ann Patchett has earned all sorts of praise for her bestseller, "State of Wonder," but as engaging as the story is, the book's science concerning a malaria vaccine left something -- well, several things -- to be desired. The reality is that with all the...
  • Looking beyond Avandia for diabetes treatment

    Looking beyond Avandia for diabetes treatment
    The safety of most diabetes drugs are time-tested — insulin was discovered in the early 1920s, and two of the other most commonly prescribed, metformin and sulfonylurea, have been around since the 1950s. Avandia is different. The drug landed with a...
  • Jailed Psychiatrist Pleads Guilty

    Jailed Psychiatrist Pleads Guilty
    Sentenced On Charges Of Falsified Records Of Clinical Trials Involving Children. DR. MARIA CARMEN PALAZZO, age 58, pled guilty in federal court today before U. S. District Judge Mary Ann Vial Lemmon to fifteen (15) counts of failing to prepare and...
  • NIH: Herpes vaccine doesn't help women

    NIH: Herpes vaccine doesn't help women
    (Reuters) - GlaxoSmithKline's herpes vaccine failed to protect women against the virus in a trial, the U.S. National Institutes of Health said Thursday, and the company said it was stopping development of the product. The test of 8,000 women in the U.S....
  • Doctors draw payments from drug companies

    Doctors draw payments from drug companies
    Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of...
  • Expectations affect benefits of pain drug

    Expectations affect benefits of pain drug
    People who don't believe their pain medicine will work can actually reduce or even cancel out the effectiveness of the drug, and images of their brains show how they are doing it, scientists report. Researchers from Britain and Germany used brain scans...
  • IUDs almost halve risk of cervical cancer: study

    IUDs almost halve risk of cervical cancer: study
    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...